Kypha Revenue and Competitors

Dublin,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Kypha's estimated annual revenue is currently $8M per year.(i)
  • Kypha's estimated revenue per employee is $251,000

Employee Data

  • Kypha has 32 Employees.(i)
  • Kypha grew their employee count by -3% last year.

Kypha's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
CEOReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Kypha?

Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.

keywords:N/A

N/A

Total Funding

32

Number of Employees

$8M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3233%N/A
#2
$3.7M32-64%N/A
#3
$3.1M3239%N/A
#4
N/A3245%N/A
#5
$5.4M3260%N/A